Aceto Corp. recently acquired Syntor Fine Chemicals.
Aceto is a virtual manufacturer of materials for life sciences, nutrition, agricultural and advanced technology end markets, and a New Mountain Capital portfolio company.
According to Aceto, the acquisition is a step in its life sciences strategic growth plan. Gilles Cottier, chief executive officer of Aceto, said, “Syntor’s synthesis and formulation capabilities enhance Aceto’s existing services and expand our value-added offerings in life sciences materials. With the addition of Syntor’s technical team, we can provide greater product customization in addition to supplying our current offering of high quality specialty materials.”
Simon Knowles, managing partner of Syntor adds, “The two companies are well aligned in their culture and drive to maximize value to customers through sourcing and development of complex chemistries. We believe Syntor will thrive with the support of Aceto’s global infrastructure and we look forward to contributing to the next stage of growth for the combined company.”
Syntor will operate under the name “Syntor by Aceto,” and it is expected that all employees will be retained in their current roles. The combined company will leverage the increased scale of Syntor and Aceto to provide enhanced value to customers.
For more information, contact Aceto Corp.